303 related articles for article (PubMed ID: 19204985)
21. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.
Chang CW; Lai YS; Pawlik KM; Liu K; Sun CW; Li C; Schoeb TR; Townes TM
Stem Cells; 2009 May; 27(5):1042-9. PubMed ID: 19415770
[TBL] [Abstract][Full Text] [Related]
22. A protein roadmap to pluripotency and faithful reprogramming.
Wang J; Orkin SH
Cells Tissues Organs; 2008; 188(1-2):23-30. PubMed ID: 18196921
[TBL] [Abstract][Full Text] [Related]
23. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
Liu X; Huang J; Chen T; Wang Y; Xin S; Li J; Pei G; Kang J
Cell Res; 2008 Dec; 18(12):1177-89. PubMed ID: 19030024
[TBL] [Abstract][Full Text] [Related]
24. Nuclear reprogramming and pluripotency of embryonic cells: Application to the isolation of embryonic stem cells in farm animals.
Renard JP; Maruotti J; Jouneau A; Vignon X
Theriogenology; 2007 Sep; 68 Suppl 1():S196-205. PubMed ID: 17610945
[TBL] [Abstract][Full Text] [Related]
25. Viable iPSC mice: a step closer to therapeutic applications in humans?
Betts DH; Kalionis B
Mol Hum Reprod; 2010 Feb; 16(2):57-62. PubMed ID: 19952032
[TBL] [Abstract][Full Text] [Related]
26. Mouse induced pluripotent stem cells.
Geoghegan E; Byrnes L
Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
[TBL] [Abstract][Full Text] [Related]
27. Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle.
Han DW; Do JT; Gentile L; Stehling M; Lee HT; Schöler HR
Stem Cells; 2008 Feb; 26(2):445-54. PubMed ID: 18065396
[TBL] [Abstract][Full Text] [Related]
28. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
Narazaki G; Uosaki H; Teranishi M; Okita K; Kim B; Matsuoka S; Yamanaka S; Yamashita JK
Circulation; 2008 Jul; 118(5):498-506. PubMed ID: 18625891
[TBL] [Abstract][Full Text] [Related]
29. Induction and isolation of vascular cells from human induced pluripotent stem cells--brief report.
Taura D; Sone M; Homma K; Oyamada N; Takahashi K; Tamura N; Yamanaka S; Nakao K
Arterioscler Thromb Vasc Biol; 2009 Jul; 29(7):1100-3. PubMed ID: 19423866
[TBL] [Abstract][Full Text] [Related]
30. Genome modification in human embryonic stem cells.
Tenzen T; Zembowicz F; Cowan CA
J Cell Physiol; 2010 Feb; 222(2):278-81. PubMed ID: 19877154
[TBL] [Abstract][Full Text] [Related]
31. The promise of human induced pluripotent stem cells for research and therapy.
Nishikawa S; Goldstein RA; Nierras CR
Nat Rev Mol Cell Biol; 2008 Sep; 9(9):725-9. PubMed ID: 18698329
[TBL] [Abstract][Full Text] [Related]
32. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.
Atkinson S; Armstrong L
Cell Tissue Res; 2008 Jan; 331(1):23-9. PubMed ID: 18004593
[TBL] [Abstract][Full Text] [Related]
33. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
[TBL] [Abstract][Full Text] [Related]
34. Induced human pluripotent stem cells: promises and open questions.
Rolletschek A; Wobus AM
Biol Chem; 2009 Sep; 390(9):845-9. PubMed ID: 19558327
[TBL] [Abstract][Full Text] [Related]
35. Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts.
Tsubooka N; Ichisaka T; Okita K; Takahashi K; Nakagawa M; Yamanaka S
Genes Cells; 2009 Jun; 14(6):683-94. PubMed ID: 19476507
[TBL] [Abstract][Full Text] [Related]
36. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.
Aasen T; Raya A; Barrero MJ; Garreta E; Consiglio A; Gonzalez F; Vassena R; Bilić J; Pekarik V; Tiscornia G; Edel M; Boué S; Izpisúa Belmonte JC
Nat Biotechnol; 2008 Nov; 26(11):1276-84. PubMed ID: 18931654
[TBL] [Abstract][Full Text] [Related]
37. [Induced pluripotent stem cells].
Shevchenko AI; Medvedev SP; Mazurok NA; Zakiian SM
Genetika; 2009 Feb; 45(2):160-8. PubMed ID: 19334609
[TBL] [Abstract][Full Text] [Related]
38. Reprogramming of DNA replication timing.
Shufaro Y; Lacham-Kaplan O; Tzuberi BZ; McLaughlin J; Trounson A; Cedar H; Reubinoff BE
Stem Cells; 2010 Mar; 28(3):443-9. PubMed ID: 20073043
[TBL] [Abstract][Full Text] [Related]
39. [Induced pluripotent stem cells (iPS cells)].
Germain D
Pathol Biol (Paris); 2009; 57(7-8):555-9. PubMed ID: 19880264
[TBL] [Abstract][Full Text] [Related]
40. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors.
Niwa A; Umeda K; Chang H; Saito M; Okita K; Takahashi K; Nakagawa M; Yamanaka S; Nakahata T; Heike T
J Cell Physiol; 2009 Nov; 221(2):367-77. PubMed ID: 19562687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
